SHIRE; Steven J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for SHIRE; Steven J..The latest application filed is for "high concentration antibody and protein formulations".
Company Profile
2.23.31
- SHIRE; Steven J. - Belmont CA
- Shire; Steven J. - South San Francisco CA
- Shire; Steven J. - Emerald Hills CA US
- Shire; Steven J - Belmont CA
- Shire; Steven J. - San Mateo CA
Patent Activity
| Patent | Date |
|---|---|
| High Concentration Antibody And Protein Formulations App 20190358323 - LIU; Jun ; et al. | 2019-11-28 |
| Reduced-viscosity Concentrated Protein Formulations App 20190231875 - LIU; Jun ; et al. | 2019-08-01 |
| Reduced-viscosity concentrated protein formulations Grant 10,166,293 - Liu , et al. J | 2019-01-01 |
| High concentration antibody and protein formulations Grant 10,034,940 - Liu , et al. July 31, 2 | 2018-07-31 |
| High Concentration Antibody And Protein Formulations App 20170049888 - LIU; Jun ; et al. | 2017-02-23 |
| Reduced-viscosity Concentrated Protein Formulations App 20160367675 - LIU; Jun ; et al. | 2016-12-22 |
| Protein formulation Grant 9,283,273 - Andya , et al. March 15, 2 | 2016-03-15 |
| Treating a mammal with a formulation comprising an antibody which binds IgE Grant 9,180,189 - Andya , et al. November 10, 2 | 2015-11-10 |
| High Concentration Antibody And Protein Formulations App 20150225485 - LIU; Jun ; et al. | 2015-08-13 |
| High concentration antibody and protein formulations Grant 8,961,964 - Liu , et al. February 24, 2 | 2015-02-24 |
| Reduced-viscosity Concentrated Protein Formulations App 20150044198 - LIU; Jun ; et al. | 2015-02-12 |
| Reduced-viscosity concentrated protein formulations Grant 8,703,126 - Liu , et al. April 22, 2 | 2014-04-22 |
| Protein Formulation App 20130224185 - Andya; James ; et al. | 2013-08-29 |
| Reduced-viscosity Concentrated Protein Formulations App 20120076783 - LIU; Jun ; et al. | 2012-03-29 |
| Reduced-viscosity concentrated protein formulations Grant 8,142,776 - Liu , et al. March 27, 2 | 2012-03-27 |
| High Concentration Antibody And Protein Formulations App 20120064086 - LIU; Jun ; et al. | 2012-03-15 |
| Methods For Treatment Of Allergic Asthma App 20110311520 - Fick; Robert B. ; et al. | 2011-12-22 |
| Protein Formulation App 20110236383 - Andya; James ; et al. | 2011-09-29 |
| Protein Formulation App 20100158899 - Andya; James ; et al. | 2010-06-24 |
| METHODS OF TREATING IgE-MEDIATED DISORDERS COMPRISING THE ADMINISTRATION OF HIGH CONCENTRATION ANTI-IgE ANTIBODY FORMULATIONS App 20100158898 - LIU; Jun ; et al. | 2010-06-24 |
| Protein formulation Grant 7,682,609 - Andya , et al. March 23, 2 | 2010-03-23 |
| Method of reducing viscosity of high concentration protein formulations Grant 7,666,413 - Liu , et al. February 23, 2 | 2010-02-23 |
| High Concentration Antibody And Protein Formulations App 20090280129 - LIU; Jun ; et al. | 2009-11-12 |
| Methods for Treatment of Allergic Asthma App 20090087426 - Fick; Robert B. ; et al. | 2009-04-02 |
| Reduced-Viscosity Concentrated Protein Formulations App 20070116700 - Liu; Jun ; et al. | 2007-05-24 |
| Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations App 20070086995 - Liu; Jun ; et al. | 2007-04-19 |
| High Concentration Antibody And Protein Formulations App 20070053900 - Liu; Jun ; et al. | 2007-03-08 |
| Methods For Treatment Of Allergic Asthma App 20070020256 - Fick; Robert B. ; et al. | 2007-01-25 |
| Protein formulation App 20060275306 - Andya; James ; et al. | 2006-12-07 |
| Protein formulation Grant 7,060,268 - Andya , et al. June 13, 2 | 2006-06-13 |
| Treating a mammal with a formulation comprising an antibody which binds IgE App 20060099201 - Andya; James ; et al. | 2006-05-11 |
| DNase liquid solutions Grant 7,018,825 - Chan , et al. March 28, 2 | 2006-03-28 |
| Purified forms of DNase Grant 6,932,965 - Frenz , et al. August 23, 2 | 2005-08-23 |
| Reduced-viscosity concentrated protein formulations App 20050175603 - Liu, Jun ; et al. | 2005-08-11 |
| Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations App 20050158303 - Liu, Jun ; et al. | 2005-07-21 |
| Reduced-viscosity concentrated protein formulations Grant 6,875,432 - Liu , et al. April 5, 2 | 2005-04-05 |
| High concentration antibody and protein formulations App 20040197324 - Liu, Jun ; et al. | 2004-10-07 |
| Method for treatment of allergic asthma App 20040197326 - Fick, Robert B. ; et al. | 2004-10-07 |
| Protein formulation Grant 6,685,940 - Andya , et al. February 3, 2 | 2004-02-03 |
| Protein formulation App 20030202972 - Andya, James ; et al. | 2003-10-30 |
| Purified forms of DNase App 20030077267 - Frenz, John ; et al. | 2003-04-24 |
| DNase Liquid solutions App 20030054532 - Chan, Hak-Kim ; et al. | 2003-03-20 |
| Purified forms of DNase Grant 6,440,412 - Frenz , et al. August 27, 2 | 2002-08-27 |
| Minimizing thermally induced aggregation of DNase in solution with calcium Grant 6,383,788 - Chan , et al. May 7, 2 | 2002-05-07 |
| Reduced-viscosity concentrated protein formulations App 20020045571 - Liu, Jun ; et al. | 2002-04-18 |
| Protein formulation App 20010014326 - Andya, James ; et al. | 2001-08-16 |
| Protein formulation Grant 6,267,958 - Andya , et al. July 31, 2 | 2001-07-31 |
| Human relaxin formulation Grant 5,945,402 - Cipolla , et al. August 31, 1 | 1999-08-31 |
| Purification and activity assurance of precipitated heterologous proteins Grant 4,512,922 - Jones , et al. April 23, 1 | 1985-04-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 